Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Underwriting Agreement
- 3.7 Form of Amendment to Certificate of Incorporation, Certificate of Series B Preferred Stock Designation
- 4.1 Form of Underwriter's Warrant
- 4.6 Form of Stock Certificate of Series B Preferred Stock
- 4.7 Form of Common Stock Purchase Warrant
- 5.1 Opinion of Lucosky Brookman LLP
- 23.1 Consent of Morison Cogen LLP, Dated December 13, 2017
TNFA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 11, 2017, contained in the Annual Report on Form 10-K for Akers Biosciences, Inc., in the Registration Statement (S-1/A) dated December 13, 2017 and the related prospectus of Akers Biosciences, Inc. included therein.
| /s/ Morison Cogen LLP | |
| Blue Bell, Pennsylvania | |
| December 13, 2017 |